Crossmark

SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC

Published Online: 2021-12-20

Published Print: 2021-12

Authors

Fu, You

Tian, Guocai

Zhang, Zhiyuan

Yang, Xiao http://orcid.org/0000-0002-5809-587X
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (grant no. 81802697)

CAMS Innovation Fund for Medical Sciences (Project No. 2019-I2M-5-037)
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-20
More Information

Article History

Received: 22 August 2021

Accepted: 5 December 2021

First Online: 20 December 2021

Declarations

:

: All producers were approved by Shanghai Jiao Tong University Animal Ethics Committee. All animal experiments operated in this research were completed in keeping with the guidelines of the Shanghai Jiao Tong University School of Medicine.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current